Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Piramal
Manufacturing
Piramal API plant in Michigan hit with FDA Form 483 write-up
The FDA has slapped Piramal with a Form 483 write-up, citing three observations from an inspection of its API plant in Riverview, Michigan.
Kevin Dunleavy
Feb 9, 2024 10:51am
Piramal gets FDA resolution in KY; begins production in MI
Feb 16, 2023 10:32am
CDMO Piramal earmarks $74M for upgrades to UK facilities
Feb 8, 2022 9:55am
GSK, Takeda, Celltrion and more—Fierce Pharma Asia
Apr 2, 2021 10:00am
Piramal continues expansion with $105M acquisition of Hemmo
Apr 1, 2021 10:55am
BioNTech-Fosun, Samsung Biologics and more—Fierce Pharma Asia
Dec 18, 2020 9:15am
